◼ Archived
Business
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
Amgen reports that combining Imdelltra with Imfinzi reduces the risk of death by 58% for patients with first-line extensive stage small cell lung cancer.